{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:13:07Z","timestamp":1791951187466,"version":"4.3.4"},"reference-count":66,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>To describe a number of the conditions associated with multiple organ dysfunction syndrome presented as part of the <jats:italic toggle=\"yes\">Eunice Kennedy Shriver<\/jats:italic> National Institute of Child Health and Human Development multiple organ dysfunction syndrome workshop (March 26\u201327, 2015).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Data Sources:<\/jats:title>\n            <jats:p>Literature review, research data, and expert opinion.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Study Selection:<\/jats:title>\n            <jats:p>Not applicable.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Data Extraction:<\/jats:title>\n            <jats:p>Moderated by an expert from the field, issues relevant to the association of multiple organ dysfunction syndrome with a variety of conditions were presented, discussed, and debated with a focus on identifying knowledge gaps and research priorities.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Data Synthesis:<\/jats:title>\n            <jats:p>Summary of presentations and discussion supported and supplemented by the relevant literature.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>There is a wide range of medical conditions associated with multiple organ dysfunction syndrome in children. Traditionally, sepsis and trauma are the two conditions most commonly associated with multiple organ dysfunction syndrome both in children and adults. However, there are a number of other pathophysiologic processes that may result in multiple organ dysfunction syndrome. In this article, we discuss conditions such as cancer, congenital heart disease, and acute respiratory distress syndrome. In addition, the relationship between multiple organ dysfunction syndrome and clinical therapies such as hematopoietic stem cell transplantation and cardiopulmonary bypass is also considered. The purpose of this article is to describe the association of multiple organ dysfunction syndrome with a variety of conditions in an attempt to identify similarities, differences, and opportunities for therapeutic intervention.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pcc.0000000000001048","type":"journal-article","created":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T12:28:18Z","timestamp":1488371298000},"page":"S50-S57","source":"Crossref","is-referenced-by-count":15,"title":["Specific Etiologies Associated With the Multiple Organ Dysfunction Syndrome in Children: Part 1"],"prefix":"10.1097","volume":"18","author":[{"given":"Jeffrey S.","family":"Upperman","sequence":"first","affiliation":[{"name":"Division of Pediatric Surgery, Children\u2019s Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Lacroix","sequence":"additional","affiliation":[{"name":"Division of Pediatric Critical Care Medicine, Department of Pediatrics, Sainte-Justine Hospital, Universit\u00e9 de Montr\u00e9al, Montreal, QC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha A. Q.","family":"Curley","sequence":"additional","affiliation":[{"name":"School of Nursing, Departments of Anesthesia and Critical Care Medicine, University of Pennsylvania, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Checchia","sequence":"additional","affiliation":[{"name":"Sections of Critical Care and Cardiology, Department of Pediatrics, Baylor College of Medicine Texas Children\u2019s Hospital, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W.","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology, Department of Pediatrics, University of Virginia, Charlottesville, VA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth R.","family":"Cooke","sequence":"additional","affiliation":[{"name":"Department of Oncology, Pediatric Blood and Marrow Transplantation Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, The Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Tamburro","sequence":"additional","affiliation":[{"name":"Pediatric Trauma and Critical Illness Branch,Eunice Kennedy ShriverNational Institute of Child Health and Human Development, National Institutes of Health, U.S. Department of Health and Human Services, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230823","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.PCC.0000149131.72248.E6","article-title":"International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics.","volume":"6","author":"Goldstein","year":"2005","journal-title":"Pediatr Crit Care Med"},{"key":"R2-20230823","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R3-20230823","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1097\/PCC.0b013e31822f177a","article-title":"Reliability of the identification of the systemic inflammatory response syndrome in critically ill infants and children.","volume":"13","author":"Juskewitch","year":"2012","journal-title":"Pediatr Crit Care Med"},{"key":"R4-20230823","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1164\/rccm.200207-682OC","article-title":"The epidemiology of severe sepsis in children in the United States.","volume":"167","author":"Watson","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"R5-20230823","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit Care Med"},{"key":"R6-20230823","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1164\/rccm.200405-630OC","article-title":"Cumulative influence of organ dysfunctions and septic state on mortality of critically ill children.","volume":"171","author":"Leclerc","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R7-20230823","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/ajrccm.149.3.7509706","article-title":"The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.","volume":"149","author":"Bernard","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"R8-20230823","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/PCC.0000000000000350","article-title":"Pediatric acute respiratory distress syndrome: Consensus recommendations from the Pediatric Acute Lung Injury Consensus Conference.","volume":"16","year":"2015","journal-title":"Pediatr Crit Care Med"},{"key":"R9-20230823","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/PCC.0000000000000432","article-title":"Pediatric acute respiratory distress syndrome: Definition, incidence, and epidemiology: Proceedings from the Pediatric Acute Lung Injury Consensus Conference.","volume":"16","author":"Khemani","year":"2015","journal-title":"Pediatr Crit Care Med"},{"key":"R10-20230823","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1097\/PCC.0000000000000431","article-title":"Pathobiology of acute respiratory distress syndrome.","volume":"16","author":"Sapru","year":"2015","journal-title":"Pediatr Crit Care Med"},{"key":"R11-20230823","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/MOP.0b013e328338da48","article-title":"The inflammatory response to injury in children.","volume":"22","author":"Wood","year":"2010","journal-title":"Curr Opin Pediatr"},{"key":"R12-20230823","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1097\/PCC.0000000000000430","article-title":"Comorbidities and assessment of severity of pediatric acute respiratory distress syndrome: Proceedings from the Pediatric Acute Lung Injury Consensus Conference.","volume":"16","author":"Flori","year":"2015","journal-title":"Pediatr Crit Care Med"},{"key":"R13-20230823","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1097\/CCM.0b013e318260caa3","article-title":"Pediatric Acute Lung Injury Epidemiology and Natural History study: Incidence and outcome of the acute respiratory distress syndrome in children.","volume":"40","author":"L\u00f3pez-Fern\u00e1ndez","year":"2012","journal-title":"Crit Care Med"},{"key":"R14-20230823","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/PCC.0000000000000184","article-title":"Nonrespiratory pediatric logistic organ dysfunction-2 score is a good predictor of mortality in children with acute respiratory failure.","volume":"15","author":"Leclerc","year":"2014","journal-title":"Pediatr Crit Care Med"},{"key":"R15-20230823","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1097\/PCC.0000000000000438","article-title":"The outcomes of children with pediatric acute respiratory distress syndrome: Proceedings from the Pediatric Acute Lung Injury Consensus Conference.","volume":"16","author":"Quasney","year":"2015","journal-title":"Pediatr Crit Care Med"},{"key":"R16-20230823","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/PCC.0b013e3181a32ffd","article-title":"Defining vasodilatory shock following cardiac surgery in children: When, where, how often?","volume":"10","author":"Checchia","year":"2009","journal-title":"Pediatr Crit Care Med"},{"key":"R17-20230823","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0022-5223(97)70231-9","article-title":"Effects of age and ischemic times on biochemical evidence of myocardial injury after pediatric cardiac operations.","volume":"113","author":"Taggart","year":"1997","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R18-20230823","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1097\/01.CCM.0000063443.32874.60","article-title":"Dexamethasone reduces postoperative troponin levels in children undergoing cardiopulmonary bypass.","volume":"31","author":"Checchia","year":"2003","journal-title":"Crit Care Med"},{"key":"R19-20230823","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jtcvs.2012.09.100","article-title":"Nitric oxide delivery during cardiopulmonary bypass reduces postoperative morbidity in children\u2013a randomized trial.","volume":"146","author":"Checchia","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R20-20230823","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/PCC.0b013e3181849a2f","article-title":"Myocardial transcriptional profiles in a murine model of sepsis: Evidence for the importance of age.","volume":"9","author":"Checchia","year":"2008","journal-title":"Pediatr Crit Care Med"},{"key":"R21-20230823","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/MPH.0b013e3181a330ef","article-title":"Prognostic factors in pediatric cancer patients admitted to the pediatric intensive care unit.","volume":"31","author":"Dursun","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"key":"R22-20230823","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/01.PCC.0000165560.90814.59","article-title":"Outcome of severe sepsis in pediatric oncology patients.","volume":"6","author":"Fiser","year":"2005","journal-title":"Pediatr Crit Care Med"},{"key":"R23-20230823","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0140-6736(14)61403-3","article-title":"T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: A phase 1 dose-escalation trial.","volume":"385","author":"Lee","year":"2015","journal-title":"Lancet"},{"key":"R24-20230823","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia.","volume":"371","author":"Maude","year":"2014","journal-title":"N Engl J Med"},{"key":"R25-20230823","doi-asserted-by":"crossref","first-page":"224ra25","DOI":"10.1126\/scitranslmed.3008226","article-title":"Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia.","volume":"6","author":"Davila","year":"2014","journal-title":"Sci Transl Med"},{"key":"R26-20230823","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1158\/1078-0432.CCR-14-2708","article-title":"A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: Long-term follow-up and correlates with response.","volume":"21","author":"Robbins","year":"2015","journal-title":"Clin Cancer Res"},{"key":"R27-20230823","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","article-title":"Current concepts in the diagnosis and management of cytokine release syndrome.","volume":"124","author":"Lee","year":"2014","journal-title":"Blood"},{"key":"R28-20230823","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nri3212","article-title":"Advances in graft-versus-host disease biology and therapy.","volume":"12","author":"Blazar","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"R30-20230823","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nri2000","article-title":"Graft-versus-host disease.","volume":"7","author":"Shlomchik","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"R31-20230823","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1164\/rccm.2007-413ST","article-title":"An official American Thoracic Society research statement: Noninfectious lung injury after hematopoietic stem cell transplantation: Idiopathic pneumonia syndrome.","volume":"183","author":"Panoskaltsis-Mortari","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"R32-20230823","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1164\/ajrccm\/147.6_Pt_1.1601","article-title":"NHLBI workshop summary. Idiopathic pneumonia syndrome after bone marrow transplantation.","volume":"147","author":"Clark","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"R33-20230823","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1164\/ajrccm\/147.6_Pt_1.1393","article-title":"Clinical course of idiopathic pneumonia after bone marrow transplantation.","volume":"147","author":"Crawford","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"R34-20230823","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/00007890-199704270-00006","article-title":"Idiopathic pneumonia syndrome: Changing spectrum of lung injury after marrow transplantation.","volume":"63","author":"Kantrow","year":"1997","journal-title":"Transplantation"},{"key":"R35-20230823","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbmt.2007.10.008","article-title":"The contribution of endothelial activation and injury to end-organ toxicity following allogeneic hematopoietic stem cell transplantation.","volume":"14","author":"Cooke","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"R36-20230823","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","article-title":"A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury.","volume":"29","author":"Jodele","year":"2015","journal-title":"Blood Rev"},{"key":"R37-20230823","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1046\/j.1365-2141.2001.02699.x","article-title":"The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation.","volume":"113","author":"Fuge","year":"2001","journal-title":"Br J Haematol"},{"key":"R38-20230823","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1537-2995.2004.00700.x","article-title":"Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: A diagnostic dilemma.","volume":"44","author":"George","year":"2004","journal-title":"Transfusion"},{"key":"R39-20230823","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3324\/haematol.10699","article-title":"Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: Results of a consensus process by an International Working Group.","volume":"92","author":"Ruutu","year":"2007","journal-title":"Haematologica"},{"key":"R40-20230823","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","article-title":"Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: A study in children and young adults.","volume":"124","author":"Jodele","year":"2014","journal-title":"Blood"},{"key":"R41-20230823","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","article-title":"Blood and marrow transplant clinical trials network toxicity committee consensus summary: Thrombotic microangiopathy after hematopoietic stem cell transplantation.","volume":"11","author":"Ho","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"R42-20230823","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.bbmt.2013.07.017","article-title":"Pulmonary hypertension after hematopoietic stem cell transplantation.","volume":"19","author":"Dandoy","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"R43-20230823","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.bbmt.2012.08.022","article-title":"Pulmonary arterial hypertension in pediatric patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy.","volume":"19","author":"Jodele","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"R44-20230823","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/sj.bmt.1704512","article-title":"Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: A clinical imitator of acute enteric graft-versus-host disease.","volume":"33","author":"Nishida","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"R45-20230823","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.bbmt.2015.06.016","article-title":"Histologic features of intestinal thrombotic microangiopathy in pediatric and young adult patients after hematopoietic stem cell transplantation.","volume":"21","author":"El-Bietar","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"R46-20230823","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2013-05-501445","article-title":"Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy.","volume":"122","author":"Jodele","year":"2013","journal-title":"Blood"},{"key":"R47-20230823","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1182\/blood-2015-08-663435","article-title":"The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy.","volume":"127","author":"Jodele","year":"2016","journal-title":"Blood"},{"key":"R48-20230823","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1537-2995.2012.03776.x","article-title":"Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy?","volume":"53","author":"Jodele","year":"2013","journal-title":"Transfusion"},{"key":"R49-20230823","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbmt.2013.12.565","article-title":"Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy.","volume":"20","author":"Jodele","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"R50-20230823","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/sj.bmt.1703414","article-title":"Defibrotide as a promising treatment for thrombotic thrombocytopenic purpura in patients undergoing bone marrow transplantation.","volume":"29","author":"Corti","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"R51-20230823","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.1840040121","article-title":"Venocclusive disease of the liver after bone marrow transplantation: Diagnosis, incidence, and predisposing factors.","volume":"4","author":"McDonald","year":"1984","journal-title":"Hepatology"},{"key":"R52-20230823","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients.","volume":"118","author":"McDonald","year":"1993","journal-title":"Ann Intern Med"},{"key":"R53-20230823","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005","article-title":"The syndrome of hepatic veno-occlusive disease after marrow transplantation.","volume":"85","author":"Bearman","year":"1995","journal-title":"Blood"},{"key":"R54-20230823","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","article-title":"Hepatic veno-occlusive disease following stem cell transplantation: Incidence, clinical course, and outcome.","volume":"16","author":"Coppell","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"R55-20230823","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","article-title":"Venoocclusive disease of the liver following bone marrow transplantation.","volume":"44","author":"Jones","year":"1987","journal-title":"Transplantation"},{"key":"R56-20230823","first-page":"439","article-title":"A comparison of clinical criteria for the diagnosis of veno-occlusive disease of the liver after bone marrow transplantation.","volume":"10","author":"Blostein","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"R57-20230823","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1200\/JCO.1993.11.9.1729","article-title":"Venoocclusive disease of the liver: Development of a model for predicting fatal outcome after marrow transplantation.","volume":"11","author":"Bearman","year":"1993","journal-title":"J Clin Oncol"},{"key":"R58-20230823","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/bjh.13215","article-title":"How I manage sinusoidal obstruction syndrome after haematopoietic cell transplantation.","volume":"168","author":"Carreras","year":"2015","journal-title":"Br J Haematol"},{"key":"R59-20230823","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/PCC.0b013e31816c7260","article-title":"Changes in outcomes (1996-2004) for pediatric oncology and hematopoietic stem cell transplant patients requiring invasive mechanical ventilation.","volume":"9","author":"Tamburro","year":"2008","journal-title":"Pediatr Crit Care Med"},{"key":"R60-20230823","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bbmt.2014.09.019","article-title":"TNF-receptor inhibitor therapy for the treatment of children with idiopathic pneumonia syndrome. A joint Pediatric Blood and Marrow Transplant Consortium and Children\u2019s Oncology Group Study (ASCT0521).","volume":"21","author":"Yanik","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"R61-20230823","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3233\/PIC-14098","article-title":"Idiopathic pneumonia syndrome following hematopoietic stem cell transplantation.","volume":"3","author":"Klein","year":"2014","journal-title":"J Ped Intensive Care"},{"key":"R62-20230823","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/2040620712441943","article-title":"Safety and efficacy of defibrotide for the treatment of severe hepatic veno-occlusive disease.","volume":"3","author":"Richardson","year":"2012","journal-title":"Ther Adv Hematol"},{"key":"R63-20230823","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(11)61938-7","article-title":"Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: An open-label, phase 3, randomised controlled trial.","volume":"379","author":"Corbacioglu","year":"2012","journal-title":"Lancet"},{"key":"R64-20230823","doi-asserted-by":"crossref","first-page":"M111.015479","DOI":"10.1074\/mcp.M111.015479","article-title":"Human biomarker discovery and predictive models for disease progression for idiopathic pneumonia syndrome following allogeneic stem cell transplantation.","volume":"11","author":"Schlatzer","year":"2012","journal-title":"Mol Cell Proteomics"},{"key":"R65-20230823","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1182\/blood-2008-07-167098","article-title":"A biomarker panel for acute graft-versus-host disease.","volume":"113","author":"Paczesny","year":"2009","journal-title":"Blood"},{"key":"R66-20230823","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMoa1213299","article-title":"ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.","volume":"369","author":"Vander Lugt","year":"2013","journal-title":"N Engl J Med"},{"key":"R67-20230823","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2352-3026(14)00035-0","article-title":"A prognostic score for acute graft-versus-host disease based on biomarkers: A multicentre study.","volume":"2","author":"Levine","year":"2015","journal-title":"Lancet Haematol"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00130478-201703001-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:21:52Z","timestamp":1692836512000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130478-201703001-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000001048","relation":{},"ISSN":["1529-7535"],"issn-type":[{"value":"1529-7535","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}